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 -Objective: The goal of this study was to assess the effectiveness of opportunistic screening 
through pulse palpation in the early detection of atrial fibrillation in subjects aged ≥ 65 years 
versus detection through an active search for patients with symptoms and/or complications and 
sequelae associated.  
-Material and methods: This was a cluster randomized controlled trial performed in 48 primary 
care centers of the Spanish National Healthcare System. A total of 368 physicians and nurses were 
randomized. The researchers in the Experimental Group (EG) performed opportunistic screening 
for auricular fibrillation, whereas the researchers in the Control Group (CG) actively searched for 
symptomatic patients. An ECG was performed on patients found to have an irregular heartbeat to 
confirm the diagnosis of auricular fibrillation.  
-Results: A total of 5,465 patients with a mean age of 75.61 were recruited for the EG, and 1,525 
patients with a mean age of 74.07 were recruited for the CG. Of these, 58.6% were female, 
without significant differences between groups. Pulse was irregular in 4.3% and 15.0% of the 
patients in the EG and the CG, respectively (p<0.001). A total of 165 new cases of atrial fibrillation 
were detected (2.3%), 1.1% in the EG and 6.7% in the CG (adjusted OR: 0.29; 95%CI: 0.18-0.45). 
-Conclusions: Case finding for atrial fibrilation in patients aged ≥ 65 years with symptoms or signs 
suggestive of atrial fibrilation is a more effective strategy than opportunistic screening through 
pulse palpation in asymptomatic patients. 
-Trial registration: the trial is registered in ClinicalTrials.gov (NCT01291953; February 8, 2011). 











































































-Objetivo: El objetivo de este estudio fue evaluar la eficacia del cribado oportunista a través de la 
palpación del pulso para la detección de  fibrilación auricular en sujetos asintomáticos de edad> 65 
años frente a la búsqueda activa de pacientes ≥ 65 años con síntomas y/o complicaciones y 
secuelas asociadas. 
-Material y métodos: Se realizó un ensayo clínico controlado aleatorizado por cluster en 48 centros 
de atención primaria del Sistema Nacional de Salud español. Se aleatorizó a un total de 368 
médicos y enfermeras. Los investigadores del grupo experimental (GE) realizaron el cribado 
oportunista para la fibrilación auricular, mientras que los investigadores del grupo control (GC) 
buscaron activamente en pacientes sintomáticos. Se realizó un ECG en los pacientes que tenían un 
pulso irregular para confirmar el diagnóstico de fibrilación auricular. 
-Resultados: Un total de 5.465 pacientes con una edad media de 75,61 fueron reclutados para la 
GE y 1.525 pacientes para el GC, con una edad media de 74,07. El 58,6% eran mujeres, sin 
diferencias significativas entre los grupos. El pulso era irregular en el 4,3% y el 15,0% de los 
pacientes del GE y el GC, respectivamente (p <0,001). Se detectaron un total de 165 nuevos casos 
de fibrilación auricular (2,3%), el 1.1% en el GE y el 6,7% en el GC (OR ajustada: 0,29; IC del 95%: 
0,18-0,45). 
-Conclusiones: la búsqueda activa a través de la palpación del pulso de fibrilación auricular en 
pacientes de edad ≥ 65 años con síntomas o signos sugestivos es una estrategia más eficaz que el 
cribado oportunista en pacientes asintomáticos. 
 
-Registro del Ensayo clínico: registrado en ClinicalTrials.gov (NCT01291953; Febrero 2011). 









































































 Atrial fibrillation (AF) is the most frequent type of sustained arrhythmia and one of the 
arrhythmias with higher associated morbidity and mortality rates. In Spain, the global prevalence 
of AF is estimated to be 4.4%, which increases to 9.3% in patients aged between 70-80 years, and 
to 17.7% in patients over 80 years1. Similarly, the PREV-ICTUS study performed in patients older 
than 60 years reported a prevalence of 8.5%2. In Europe, the Rotterdam study3 analyzed a cohort 
of patients older than 55 years and found a prevalence of 5.5%. 
 The clinical relevance of AF lies in the fact that, in its presence, the risk of having an 
ischemic stroke increases by 3.5% per year from 70 years of age. This risk can increase up to 20 
times. Fifteen percent of ischemic strokes are attributed to this type of arrhythmia; strokes related 
to AF are more severe, associated with a higher degree of disability and greater healthcare costs4. 
 A peculiarity of this arrhythmia is that it is frequently diagnosed by chance (subclinical AF). 
The FIATE registry revealed that AF was incidentally diagnosed in 26% of patients, of which 28% 
had unspecific symptoms (dizziness, fatigue, instability, anxiety or nervousness)5. The OFRECE 
study1 revealed that 10% of patients with AF were unaware they were affected by the disease. The 
studies by Labrador MS et al6 and Wheeldon NM et al7 reported a prevalence of undiagnosed AF at 
8.6% and 7.7%, respectively, in patients aged >65 years. Another study involving patients with a 
pacemaker revealed that 10.1% had subclinical atrial tachyarrhythmias, which was associated with 
a higher risk of having AF, an ischemic accident or systemic embolism8. The SMART study 
confirmed that one out of nine cryptogenic strokes had an underlying AF, whereas only 6% of 
strokes were symptomatic9. 
 A test with high specificity should be developed to identify patients at risk of having 
subclinical or asymptomatic AF10. Although numerous methods have been used for the early 
detection of arrythmia11, the most common is to take a patient’s pulse –either systematically 
(population screening) or through the use of an opportunistic approach (when patients are seen 
for other health problems)–, and if the pulse is irregular, to perform an ECG12-16. This approach has 
been proven to have high sensitivity (94%) but low specificity (72%)17. 
 To date, only two systematic reviews of studies that assess the early detection of AF have 
been published18,19. Amongst these studies opinions vary on best practices. Cochrane et al. 




































































screening, as compared to routine practice. However, their conclusions are based on the results of 
a single study. Some primary prevention guidelines recommend pulse palpation as an effective 
method for the early detection of AF in patients older than 65 or 75 years20,21. However, a recent 
publication by the UK NSC on screening for AF in adults does not recommend pulse palpation for 
the early detection of AF22 and neither the US Preventive Services Task Force, and the Canadian 
Task Force on Preventive Health Care, said screening includes among its recommendations23,24. 
Thus, detection methods remain a controversial issue.  
 Primary Care providers are in a privileged position to be proactive with patients consulting 
for emerging or non-specific symptoms and thus make early detection of serious health problems. 
 Given the scarcity of evidence available, the main goal of this study was to assess the 
effectiveness of opportunistic screening through pulse palpation in the early detection of AF in 
subjects aged >65 years versus detection through an active search for patients with symptoms 
and/or complications and sequelae associated with AF.  
  
2. Material and methods  
2.1. Design 
 The study protocol has been described in detail elsewhere25. This was a multicenter, 
parallel-arm (Experimental Group –EG– versus Control Group –CG) cluster-controlled study. The 
healthcare professionals included were randomized to perform either opportunistic screening for 
AF or detection through identification of AF symptoms. The duration of the study was 24 months, 
and the field work took 18 months. 
2.2. Participants 
 General practitioners and nurses from the Spanish National Health System were invited to 
participate in the study. Criteria for inclusion in the study consisted of being aged ≥ 65 years, 
attending the health center for other health problems and giving informed consent. Patients with 
a previous diagnosis of AF were excluded. 




































































 The main endpoint was the proportion of new cases of AF detected. The sample size was 
calculated using the results reported by Fitzmaurice14 by using the following criteria: Risk in 
exposed subjects: 1.63%; risk in non-exposed subjects: 1.012%; relative risk: 1.62; ratio: 2/1; 95% 
confidence interval, and an 80% precision. The sample size obtained was 7,722 subjects for the EG 
and 3,861 subjects for the CG. A non-response rate was estimated at 10% and adjustment was 
calculated according to the formula: Nf= Ni [1/(1-R)]=7,722 [1/(1-0.10)]= 8,580 (GE) and Nf of the 
CG= Ni [1/(1-R)]=3,861 [1/(1-0.10)]= 4,290 subjects in total. Estimates of intracluster correlation 
coefficient (ICC) in clinical trials in primary care cluster show that are generally less than 0.05 26. 
This translates CCI for a cluster size of 15, in a design effect corresponding to a factor of 1.7. Due 
to the cluster design nature of the study, it was necessary to recruit 12,870 patients from at least 
100 healthcare professionals.  
2.4. Randomisation 
 Randomization was centralized and stratified by type of healthcare professional (physician 
versus nurse) using the EPIDAT 3.1 software package. Consecutive sampling was performed by 
professionals for patient selection. 
2.5. Study variables 
The study variables are shown in table 1.  
2.6. Intervention 
The interventions involved: 
-EG: screening for AF was performed on all patients seen by participating healthcare professionals, 
regardless of the reason for the visit.  
-CG: screening was performed on any patient having symptoms suggestive of AF27 (general 
discomfort, dyspnea, chest pain, palpitations, dizziness, decreased resistance to physical activity),   
complications or sequelae potentially attributable to AF (stroke and TIA).  
 Patients included in the study were informed of the goal of the study and were asked to 
sign an informed consent form. Next, their pulse was measured and if irregular, an ECG was 




































































 The action program was as follows: 
1. A Data Collection Form and a Procedure Manual including a Clinical Protocol for the 
Management of AF was designed27.  
2. A pilot study on a sample of 20 patients randomly selected by five physicians and five nurses 
from five primary care centers was conducted. The acceptability of the target population was 
high. 
3. A communication campaign was launched using the directory of members of the Spanish 
Society of Family and Community Medicine and a directory of collaborators of the Family and 
Community Teaching Unit of Cordoba. Invitations were posted by e-mail to potential 
participants. 
4. Next, participating healthcare professionals participated in a face-to-face training session 
where the procedures of the protocol were explained and they received training in pulse 
measuring procedures. At the end of the training session, inter-observer concordance in 
pulse measuring was evaluated. Each professional was asked to measure the radial pulse of 
the subject to their left and right and record it on a data collection sheet (regular versus 
irregular pulse). Reproducibility was found to be satisfactory (simple concordance 
rate=98.8%). Although the studies performed confirm the validity of pulse palpation 
(sensitivity=76.4%-90.0%; specificity=71.0%-96.9%)17, to assess the reliability of the diagnosis 
of AF, the participating professionals were asked to interpret four ECGs selected by a 
cardiologist (two were suggestive of AF and two showed sinus rhythm) in an independent 
and blind manner. Simple concordances rates ranged between 83.7% for normal ECG and 
91.4% for ECG showing AF.  
5. A pulse was considered to be irregular when palpation showed an alteration or irregularity in 
rhythm for at least 15 seconds. When the pulse was found to be irregular, a 12-lead ECG was 
performed (along with a long L I-II-III strip. An ECG to confirm or rule out arrhythmia was 
also performed to patients with questionable or inconclusive pulse. Apart from AF, 
professionals were asked to check for other electrocardiographic alterations (table 1). ECGs 




































































186 patients with regular pulse ECG were asked to investigate other possible cardiac 
abnormalities, so in these patients the protocol was not strictly followed. 
2.7. Statistical analysis 
 Statistical analysis was performed using the EPIDAT 3.1, SPSS 17.0 and MLwiN 2.02. 
software packages. A descriptive analysis was performed. To check the differences between the 
groups and previous verification of normality (Shapiro-Wilk), Chi-squared and T Student tests was 
applied. The relationship between the type of intervention and AF was assessed by the chi-
squared test (p<0.05). We also calculated the Relative Risk (RR), Absolute Risk Reduction (ARR), 
and the Number Needed to Screen (NNS). Multivariate analysis was performed to adjust the main 
dependent variable (AF) for prognostic variables or predictors and/or confounders. Since 
randomization was by cluster, a multi-level regression analysis was first performed (level 1: 
professional; level 2: patients). The results showed that the potential cluster effect did not have 
any influence; therefore, we performed a multiple logistic regression analysis. Modeling was 
performed using the Enter method in the SPSS software package. The goodness of fit of the model 
was evaluated by the Hosmer-Lemeshow test. 
2.8. Ethical aspects 
 The study was approved by the Ethics Committee for Clinical Research of Córdoba and the 
Ethics Committee for Clinical Research of Mataró Hospital, Barcelona. The study design was 
developed according to CONSORT Declaration recommendations for cluster-randomized clinical 











































































 A total of 218 general practitioners and 101 nurses from 48 primary care centers located in 
20 provinces in Spain performed patient recruitment. Figure 1 shows a diagram of the study. A 
total of 6,990 patients were recruited (5,465 for the EG and 1,525 for the CG).  
 Table 2 shows an  analysis of the study variables concerning both healthcare professionals 
and patients by group. Patient's mean age was higher in the CG as compared to the EG (75.61 vs. 
74.07). An appreciable difference was observed in the comparison of groups by age, as there were 
more patients in the 80-85 year and >85 years category in the CG (9.3 % vs. 5.6%). In total, 63.4% 
of patients were recruited by GPs versus 36.6% who were enrolled by nurses. A total of 90.2% of 
patients were recruited in primary care. A higher number of cardiovascular risk factors and 
associated morbidity (obesity, alcoholism, tobacco use, heart failure, hyperthyroidism and valvular 
heart disease) were observed in CG patients, as compared to EG patients.  
 Pulse palpation revealed an irregular pulse in 234 EG patients (4.3%), and the results were 
uncertain or inconclusive in 108 (2.0%). The proportion of patients in the CG with an irregular 
pulse was 15.0%, and pulse could not be certainly determined in 7.6%. 
 In respect to the reasons for the medical visit, 87.9% of EG patients had no AF symptoms 
versus 3.0% of CG patients who had no AF symptoms but had some complication or sequelae 
suggestive of AF (frequently, a cerebrovascular stroke). The most frequent symptoms were: 
dyspnea, dizziness, palpitations, chest pain and decreased resistance to physical activity. 
 A total of 164 new cases of AF (2.34%) were detected, of which 61 were EG patients (1.1%) 
and 103 were GC patients (6.8%). As shown in table 3, the RR was 0.16 (95%CI:0.11-0.21), the ARR 
was 5.70% (95%CI:4.77-6.49%) in favor of the CG, and the NNS was 17.7 (95%CI:14.4 to 23.0). 
Other electrocardiographic alterations were detected in 4.4% of patients (2.8% in the EG vs. 10.0% 
in the CG). In this case, the RR was 0.20 (95%CI:0.16-0.25), the ARR was 9.0% (95%CI:8.0-11.0%) 
and the NNS was 10.64 (95%CI:8.99-13.02). 
 The effects of the two interventions tested for the detection of new cases of AF are shown 
in table 4. Logistic regression was performed for adjustment for the independent variables. The OR 





































































4. Discussion  
 This study reveals that an active, selective search for symptomatic patients allows 
detection of up to 71% more new cases of AF (adjusted OR=0.29) than opportunistic screening 
through pulse palpation indiscriminately performed on all patients aged 65 years or older 
attended by a primary care center of the Spanish National Health System.  
 For a detection test to be recommended as an effective screening method, it must fulfill 
certain requirements concerning: 
 The condition, such as prevalence, relevance, defined latency period, cost-effectiveness, 
etc;  
 the method, which must be simple, safe, valid, reliable, efficient and acceptable by the 
target population;  
 the confirmatory diagnosis and treatment, with evidence of effectiveness, possibility of 
performing it in the pre-symptomatic phase;  
 and the preventive program, which must be evaluable, acceptable and feasible7.  
 
 Screening for AF through pulse palpation complies with many of, though not all of, these 
requirements. 
 At present, only two approaches are used for the early detection of AF: systematic 
screening (an ECG is performed on all patients) or opportunistic screening (pulse is measured on 
all patients and, when irregular, an ECG is performed to confirm the diagnostic). To assess the 
effectiveness of these tests in detecting AF, they have to be compared with the effectiveness of 
routine practice18. In our study we tested an alternative approach: comparing opportunistic 
screening versus an active, selective search for patients (case finding) with symptoms and/or signs 
suggestive of AF. 
 Only two systematic reviews have been published that assess the early detection of AF18,19. 
Both concluded that the only evaluable study was one which compared two screening procedures 
(systematic versus opportunistic) with routine practice14. Several clinical guidelines recommend 
opportunistic screening for AF20,21, although such recommendations are exclusively based on the 
results of the only study considered evaluable14. However, a number of recent reviews dismiss the 




































































evidence demonstrating that screening patients with symptoms of AF is more effective than 
screening asymptomatic patients. To date, it has not been demonstrated that the prognosis of AF 
detected through screening is better than that when it is detected through routine practice.  
 Up to the present, no studies have been conducted that compare the effectiveness of 
actively searching for new cases of AF among patients with associated symptoms or complications 
versus screening through pulse palpation. A recent review highlights the relevance of subclinical 
AF in the prognosis and management of patients, since a timely preventive treatment would 
reduce the number of strokes and other associated complications28. 
 In our study, the number of new cases of AF detected in the EG through pulse palpation 
(1.1%) was similar to that identified in previous studies (1.4% for patients aged ≥65 years) included 
in the systematic review by Lowres et al19; these studies used pulse palpation or ECG to perform a 
single time-point screening. It is also to be noted that the detection rate in the EG is similar to that 
reported in other studies such as that by Morgan et al12 (1.3%) and SanMartin et al29 (1.0%), and 
slightly lower when compared to Fitzmaurice et al14 (1.6% through screening versus 1% detected 
through routine practice). Consequently, to detect new cases of AF using this method, between 
7130 and 16714more subjects would have to be screened. These modest results should be 
considered by the relevant authorities when it comes to implementing preventive activities, since 
such results may deter the authorities from supporting screening. On the other hand, if 
opportunistic screening is compared with an active search for symptomatic patients –as was done 
in our study–, only 17-18 patients older than 65 would need to be screened to detect an additional 
case of AF. These results clearly support active selective searching for symptomatic patients. In 
addition, we detected a high number of other ECG alterations, which were four times more 
frequent in the CG than in the EG. Some of these alterations –other atrial tachyarrhythmias– are 
related to the development of cryptogenic strokes. 
 This study has some limitations. The sample size was below the size initially calculated; 
therefore, a beta error may have occurred. To calculate the sample size, we based our 
investigation on the results of the study by Fitzmaurice14, as it was the only study comparable with 
ours. However, given the noticeable difference found in the incidence of AF between the two 
groups, we believe that this study has enough statistical power to test the statistical hypothesis. 
Number of losses for not recruit patients was higher in the EG (15.0%) than in the CG (11.5%), 




































































EG, since doctors performed more diagnostic research than nurses (OR=1.54); However, this 
variable (the provider) was controlled in the multivariate análisis. Additionally, some professionals 
who were willing to participate were excluded for not having recruited any patients; however, the 
number of exclusions was low and similar in both groups. There were no lost to follow-ups, which 
can be explained by the fact that no follow-up was required for these patients. Finally, researchers 
in the CG may have been more affected by the Hawthorne effect –or observer effect– than those 
in the EG. This may reduce the possibility of extrapolating the results obtained, since the effects 
obtained with respect to the procedures used in routine practice might be overestimated.  
 Although the results reported in this study may seem inconsistent with those of the 
systematic reviews published, this is not the case as, to date, opportunistic screening has never 
been compared with an active, selective search for patients with symptoms and/or signs 
suggestive of AF. In fact, this is the first study to compare and analyze differences between the 
two strategies. While further studies should be conducted to corroborate our findings, our 
conclusions are consistent with recent guidelines, which do not recommend performing non-
selective opportunistic screening for AF in patients aged 65 years or older22. Moreover, 
organizations such as US Preventive Services Task Force and the Canadian Task Force on 
Preventive Health Care, not even take into account in its recommendations Opportunistic 
screening for atrial fibrillation23,24. Systematic population screening programme not 
recommended, clinical practice guidelines covered by NICE 31. According to the recommendations 
on the management of AF made by NICE in 2014 32, only it is advisable perform manual pulse 
palpation to assess for the presence of an irregular pulse that may indicate underlying atrial 
fibrillation in people presenting with any of the following symptoms or problems: 
breathlessness/dyspnoea, palpitations, syncope/dizziness, chest discomfort, or stroke/transient 
ischaemic  attack. 
 In conclusion, screening for AF in patients aged ≥ 65 years with symptoms or signs 
suggestive of AF in primary care is a more effective strategy for the early detection of AF than 
opportunistic screening through pulse palpation in asymptomatic patients. Also, screening allows 
the diagnosis of other unnoticed heart rhythm disorders. The study results show that primary care 
professionals could detect up to 6% of new atrial fibrillation cases in people presenting any of the 
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Study Group EG: opportunistic detection 
CG: regular approach 
Healthcare Professional 
involved 
Physician vs. Nurse 
Location Province where the healthcare center is located 
-Sociodemographic:  
Age ≥ 65 years 
Sex Male/female 
Educational Level No education, can read and write, primary education, secondary education, 
higher education 
Civil Status Single, married, widow/widower, divorced-separated 




Place of enrollment Office, emergency room, home visit 
Symptoms and Signs Asymptomatic, general discomfort, dyspnea, chest pain, palpitations, dizziness, 
decreased resistance to physical activity, embolic complications or exacerbation 
of heart failure. 
Conditions (comorbidity) 
and associated health 
   Obesity, hypertension, diabetes mellitus, dyslipidemia, smoking, alcohol abuse, 
ischemic heart disease, peripheral artery disease, cerebrovascular accident 




































































problems hyperthyroidism, hypothyroidism, anxiety-depression, COPD, Other conditions 
DEPENDENTS:  
Peripheral arterial pulse 
Atrial Fibrillation 
Other ECG disorders 
 
Radial pulse: Regular, irregular or uncertain 
Atrial Fibrilation confirmed by electrocardiogram following clinical protocol 
Flutter, Extrasystole (ventricular / supraventricular / other), tachycardia, atrial 
Bigeminy, ventricular Bigeminy, bundle branch block, ventricular premature 






























































































































































Sex: n (%) 
   Men 







Occupation: n (%) 
   Family Medicine 







Location: n (%) 
   Barcelona 
   Córdoba 

















Age Groups (years): n (%) 
   65 to 69 
   70 to 74 
   75 to 79 
   80 to 84 













Sex:  n (%)  
    Men 







Civil Status: n (%) 
   Married 
   Widow/er 
   Divorced 








 44 (2.9) 
92 (6.0) 
488 (32.0) 
Educational Level: n (%) 
   No education 
   Can read and write 
   Primary Education 
   Secondary Education 













Place of residence; n (%) 
   Barcelona 
   Córdoba 














































































Table 2 (continuation) 
Patients recruited by occupation: n (%) 
   Family Medicine 







Place of patient recruitment: n (%) 
   Office 
   Emergency Room 













Signs and symptoms associated with potential AF: n (%) 
   Asymptomatic  
   Dyspnoea   
   Chest Pain  
   Palpitations  
   Dizziness  
   Decreased resistance to physical activity 
   Ankle edema   
   General Discomfort 





















Number of signs and symptoms:  mean±SD (limits)               0.17±0.52 (0-5) 1.40±0.76 (0-5) 
Pulse rate: n (%) 
   Regular 







Electrocardiogram results: n (%) 
-Performed (n=864;12,9%) 
 Normal 
 Atrial Fibrilation  
 Flutter  
 Ventricular premature beats 


















































































 Paroxysmal supraventricular tachycardia 
 Sinus tachycardia 
 Atrial tachycardia  
 Headphone bigeminy 
   Ventricular bigeminy 
   Branch block 
   Other changes on elechtrocardiogram 

















Morbidity: n (%) 
   Obesity  
 Arterial hypertension 
    Mellitus diabetes 
    Dyslipidemia 
    Smoking 
    Acoholism 
    Ischemic heart disease 
    PAD 
    Cerebrovascular accident (Stroke, TIA) 
    Valvular 
    Left ventricular hypertrophy 
    Heart failure 
    Hyperthyroidism 
    Hypothyroidism 
    Anxiety-depression 
    COPD 





































Number of conditions:  mean±SD (limits) 2.32±1.48 (0-9) 2.48±1.41 (0-7) 
Signs and symptoms associated with potential AF: n (%) 
   Asymptomatic  
   Dyspnoea   
   Chest Pain  
   Palpitations  
















































































   Decreased resistance to physical activity 
   Ankle edema   
   General Discomfort 





































































































Table 3. Cases of atrial fibrillation and other electrocardiographic alterations detected by group. 






















(14.4 a 23.0) 
Experimental 5465 (78.2) 61 (1.10) 
























Experimental 5465 (78.2) 152 (2.8) 
Total  6990 (100.0) 307 (4.4) 








































































Table 4. Detected cases of atrial fibrillation by group, adjusted according to the predictor variables 
studied 
Variables in the model B p OR IC 95% de OR 
Group (Experimental  vs. Control) -1.247 <0.001 0.29 0.18-0.45 
Occupation (Physician vs. Nurse) 0.435 0.042 1.54 1.02-2.35 
Place of recruitment (category of reference: office):  
Emergency Room 0.646 0.009 1.91 1.17-3.09 
Home Visit 1.630 <0.001 5.10 2.68-9.72 
Age group (category of reference: 65 to 69 years):  
70 to 74 0.388 0.194 1.47 0.82-2.65 
75 to 79 0.594 0.048 1.81 1.00-3.27 
80 to 84 1.122 <0.001 3.07 1.66-5.65 
85 or more 1.670 <0.001 5.31 2.75-10.27 
Sex (Men vs. Women) 0.722 <0.001 2.06 1.37-3.08 
Civil Status (category of reference: widow/er)  
Married 0.062 0.780 1.06 0.69-1.65 
Separated -0.514 0.485 0.59 0.14-2.53 
Single 0.296 0.455 1.34 0.62-2.92 
Educational level (category of reference: no education):  
Can read and write -0.285 0.214 0.75 0.48-1.19 
Primary Education -0.174 0.613 0.84 0.43-1.65 




































































Higher Education 0.098 0.822 1.10 0.47-2.57 
Number of symptoms 0.093 0.459 1.10 0.86-1.40 
Arterial rate  0.075 <0.001 1.08 1.07-1.09 
Obesity 0.600 0.062 1.82 0.97-3.42 
High Blood Pressure 0.707 0.022 2.03 1.11-3.71 
Diabetes Mellitus -0.166 0.578 0.85 0.47-1.52 
Dyslipemia 0.141 0.614 1.15 0.66-1.99 
Tobacco use 0.592 0.237 1.81 0.68-4.81 
Alcoholism -0.192 0.799 0.83 0.19-3.62 
Ischemic Heart Disease  0.257 0.526 1.29 0.58-2.86 
Peripheral Artery Disease 1.340 0.009 3.82 1.40-10.44 
Vasculocerebral Accident 0.189 0.698 1.21 0.46-3.14 
Valvular heart disease -0.820 0.344 0.44 0.08-2.41 
Left Ventricular Hypertrophy 1.345 0.041 3.84 1.06-13.93 
Heart Failure 0.175 0.808 1.19 0.29-4.92 
Hyperthyroidism 0.211 0.840 1.23 0.16-9.56 
Anxiety/Depression 0.030 0.965 1.03 0.26-4.03 
Hypothyroidism 0.502 0.414 1.65 0.49-5.52 
Chronic obstructive pulmonary disease 0.006 0.990 1.01 0.38-2.68 
Number of pathologies -0.320 0.135 0.73 0.48-1.10 
Constant -10.707  
n=6990; OR: Odds Ratio; 95%CI: 95% Confidence Interval; Omnibus test:515,886; p<0,001; Hosmer-

































































































368 professionals recruited from  48 primary care centers 
Experimental group: opportunistic screening 
n=186 (118 physicians and 58 nurses) 
Exclusions (for nor recruiting any patients)=28 
 (16 physicians and 12 nurses) 
Final participants: 158 (102 physicians and 56 
nurses) 
Control Group: Detection of symptomatic cases 
n=182 (126 physicians and 56 nurses 
Exclusions (for not recruiting any patients)=21  
(10 physicians and 11 nurses) 
Final participants: 161 (116 physicians and 45 
nurses) 
  
 Stratified cluster randomization by 
type of professional (physician vs. 
nurse) 
Patients included: 5465  
(mean/occupation: 34; limits: 1-57) 
Cases of atrial fibrilation detected: 
61 (1,1%) 
Patients included: 1525  
(mean/occupation: 10; limits: 1-27) 
Cases of atrial fibrillation detected: 
103 (6,8%) 
 Detection of new 
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